Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH)

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 7, 2014, Pages 959-970

  Jha, Pooja ^a,b   Knopf, Astrid ^b   Koefeler, Harald ^b   Mueller, Michaela ^a,b   Lackner, Carolin ^b   Hoefler, Gerald ^b   Claudel, Thierry ^a   Trauner, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

ATGL; FGF21; HSL; Lipolysis; Liver; NAFLD

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CHOLINE; FATTY ACID; FATTY ACID BINDING PROTEIN 4; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; HORMONE SENSITIVE LIPASE; METHIONINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL LIPASE; UNCOUPLING PROTEIN 1;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL SIZE; CONTROLLED STUDY; DISEASE COURSE; ENERGY EXPENDITURE; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIPOLYSIS; LIVER; LIVER INJURY; MACROPHAGE; METHIONINE CHOLINE DEFICIENCY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL DEFICIENCY; OBESITY; PATHOGENESIS; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ISOLATION; VITAMIN DEFICIENCY; WESTERN BLOTTING;

ATGL; FGF21; HSL; LIPOLYSIS; LIVER; NAFLD;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; CHOLINE; DISEASE MODELS, ANIMAL; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; FIBROBLAST GROWTH FACTORS; INFLAMMATION; LIPASE; LIPID METABOLISM; LIPOLYSIS; LIVER; METHIONINE; MICE; OBESITY; OXIDATION-REDUCTION;

EID: 84897422306     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.02.012     Document Type: Article

References (54)

1. Angulo Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002, 346:1221-1231.
2. Adams L.A. Nonalcoholic fatty liver disease and diabetes mellitus. Endocr. Res. 2007, 32:59-69.
3. Jha P., Claudel T., Baghdasaryan A., Mueller M., Halilbasic E., Das S.K., Lass A., Zimmermann R., Zechner R., Hoefler G., Trauner M. Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia. Hepatology 2014, 59:858-869.
4. Hebbard L., George J. Animal models of nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 2011, 8:35-44.
5. Henao-Mejia J., Elinav E., Jin C., Hao L., Mehal W.Z., Strowig T., Thaiss C.A., Kau A.L., Eisenbarth S.C., Jurczak M.J., Camporez J.P., Shulman G.I., Gordon J.I., Hoffman H.M., Flavell R.A. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
6. Rivera C.A., Adegboyega P., van Rooijen N., Tagalicud A., Allman M., Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J. Hepatol. 2007, 47:571-579.
7. Vance D.E. Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis. Curr. Opin. Lipidol. 2008, 19:229-234.
8. Caballero F., Fernandez A., Matias N., Martinez L., Fucho R., Elena M., Caballeria J., Morales A., Fernandez-Checa J.C., Garcia-Ruiz C. Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione. J. Biol. Chem. 2010, 285:18528-18536.
9. Mato J.M., Martinez-Chantar M.L., Lu S.C. Methionine metabolism and liver disease. Annu. Rev. Nutr. 2008, 28:273-293.
10. Tilg H., Moschen A.R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010, 52:1836-1846.
11. Day C.P., James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 1998, 114:842-845.
12. Cohen J.C., Horton J.D., Hobbs H.H. Human fatty liver disease: old questions and new insights. Science 2011, 332:1519-1523.
13. Donnelly K.L., Smith C.I., Schwarzenberg S.J., Jessurun J., Boldt M.D., Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 2005, 115:1343-1351.
14. Trauner M., Arrese M., Wagner M. Fatty liver and lipotoxicity. Biochim. Biophys. Acta 2010, 1801:299-310.
15. Puri P., Wiest M.M., Cheung O., Mirshahi F., Sargeant C., Min H.K., Contos M.J., Sterling R.K., Fuchs M., Zhou H., Watkins S.M., Sanyal A.J. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009, 50:1827-1838.
16. Puri P., Baillie R.A., Wiest M.M., Mirshahi F., Choudhury J., Cheung O., Sargeant C., Contos M.J., Sanyal A.J. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007, 46:1081-1090.
17. Neuschwander-Tetri B.A. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 2010, 52:774-788.
18. Duncan R.E., Ahmadian M., Jaworski K., Sarkadi-Nagy E., Sul H.S. Regulation of lipolysis in adipocytes. Annu. Rev. Nutr. 2007, 27:79-101.
19. Johansson L., Roos M., Kullberg J., Weis J., Ahlstrom H., Sundbom M., Eden Engstrom B., Karlsson F.A. Lipid mobilization following Roux-en-Y gastric bypass examined by magnetic resonance imaging and spectroscopy. Obes. Surg. 2008, 18:1297-1304.
20. Haemmerle G., Lass A., Zimmermann R., Gorkiewicz G., Meyer C., Rozman J., Heldmaier G., Maier R., Theussl C., Eder S., Kratky D., Wagner E.F., Klingenspor M., Hoefler G., Zechner R. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006, 312:734-737.
21. Haemmerle G., Zimmermann R., Hayn M., Theussl C., Waeg G., Wagner E., Sattler W., Magin T.M., Wagner E.F., Zechner R. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J. Biol. Chem. 2002, 277:4806-4815.
22. Zechner R., Zimmermann R., Eichmann T.O., Kohlwein S.D., Haemmerle G., Lass A., Madeo F. FAT SIGNALS-lipases and lipolysis in lipid metabolism and signaling. Cell Metab. 2012, 15:279-291.
23. Bezaire V., Langin D. Regulation of adipose tissue lipolysis revisited. Proc. Nutr. Soc. 2009, 68:350-360.
24. Schweiger M., Schreiber R., Haemmerle G., Lass A., Fledelius C., Jacobsen P., Tornqvist H., Zechner R., Zimmermann R. Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J. Biol. Chem. 2006, 281:40236-40241.
25. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37:911-917.
26. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., Sanyal A.J. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321. N. Nonalcoholic Steatohepatitis Clinical Research.
27. Rinella M.E., Elias M.S., Smolak R.R., Fu T., Borensztajn J., Green R.M. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J. Lipid Res. 2008, 49:1068-1076.
28. Peng X.G., Ju S., Fang F., Wang Y., Fang K., Cui X., Liu G., Li P., Mao H., Teng G.J. Comparison of brown and white adipose tissue fat fractions in ob, seipin, and Fsp27 gene knockout mice by chemical shift-selective imaging and (1)H-MR spectroscopy. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E160-E167.
29. Emanuelli B., Vienberg S.G., Smyth G., Cheng C., Stanford K.I., Arumugam M., Michael M.D., Adams A.C., Kharitonenkov A., Kahn C.R. Interplay between FGF21 and insulin action in the liver regulates metabolism. J. Clin. Invest. 2014, 124:515-527.
30. Kharitonenkov A., Shiyanova T.L., Koester A., Ford A.M., Micanovic R., Galbreath E.J., Sandusky G.E., Hammond L.J., Moyers J.S., Owens R.A., Gromada J., Brozinick J.T., Hawkins E.D., Wroblewski V.J., Li D.S., Mehrbod F., Jaskunas S.R., Shanafelt A.B. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 2005, 115:1627-1635.
31. Coskun T., Bina H.A., Schneider M.A., Dunbar J.D., Hu C.C., Chen Y., Moller D.E., Kharitonenkov A. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 2008, 149:6018-6027.
32. Inagaki T., Dutchak P., Zhao G., Ding X., Gautron L., Parameswara V., Li Y., Goetz R., Mohammadi M., Esser V., Elmquist J.K., Gerard R.D., Burgess S.C., Hammer R.E., Mangelsdorf D.J., Kliewer S.A. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 2007, 5:415-425.
33. Plaisance E.P., Greenway F.L., Boudreau A., Hill K.L., Johnson W.D., Krajcik R.A., Perrone C.E., Orentreich N., Cefalu W.T., Gettys T.W. Dietary methionine restriction increases fat oxidation in obese adults with metabolic syndrome. J. Clin. Endocrinol. Metab. 2011, 96:E836-E840.
34. Plaisance E.P., Henagan T.M., Echlin H., Boudreau A., Hill K.L., Lenard N.R., Hasek B.E., Orentreich N., Gettys T.W. Role of beta-adrenergic receptors in the hyperphagic and hypermetabolic responses to dietary methionine restriction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R740-R750.
35. Hasek B.E., Stewart L.K., Henagan T.M., Boudreau A., Lenard N.R., Black C., Shin J., Huypens P., Malloy V.L., Plaisance E.P., Krajcik R.A., Orentreich N., Gettys T.W. Dietary methionine restriction enhances metabolic flexibility and increases uncoupled respiration in both fed and fasted states. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R728-R739.
36. Malloy V.L., Krajcik R.A., Bailey S.J., Hristopoulos G., Plummer J.D., Orentreich N. Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer 344 rats independent of energy restriction. Aging Cell 2006, 5:305-314.
37. Scherer T., O'Hare J., Diggs-Andrews K., Schweiger M., Cheng B., Lindtner C., Zielinski E., Vempati P., Su K., Dighe S., Milsom T., Puchowicz M., Scheja L., Zechner R., Fisher S.J., Previs S.F., Buettner C. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab. 2011, 13:183-194.
38. Yao Z.M., Vance D.E. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J. Biol. Chem. 1988, 263:2998-3004.
39. Leclercq I.A., Farrell G.C., Schriemer R., Robertson G.R. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J. Hepatol. 2002, 37:206-213.
40. Rahman S.M., Schroeder-Gloeckler J.M., Janssen R.C., Jiang H., Qadri I., Maclean K.N., Friedman J.E. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis. Hepatology 2007, 45:1108-1117.
41. Mathurin P., Hollebecque A., Arnalsteen L., Buob D., Leteurtre E., Caiazzo R., Pigeyre M., Verkindt H., Dharancy S., Louvet A., Romon M., Pattou F. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 2009, 137:532-540.
42. Hafeez S., Ahmed M.H. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?. J. Obes. 2013, 2013:839275.
43. Das S.K., Eder S., Schauer S., Diwoky C., Temmel H., Guertl B., Gorkiewicz G., Tamilarasan K.P., Kumari P., Trauner M., Zimmermann R., Vesely P., Haemmerle G., Zechner R., Hoefler G. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science 2011, 333:233-238.
44. Hoffstedt J., Arner P., Hellers G., Lonnqvist F. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J. Lipid Res. 1997, 38:795-804.
45. van der Poorten D., Milner K.L., Hui J., Hodge A., Trenell M.I., Kench J.G., London R., Peduto T., Chisholm D.J., George J. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008, 48:449-457.
46. Leclercq I.A., Farrell G.C., Field J., Bell D.R., Gonzalez F.J., Robertson G.R. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J. Clin. Invest. 2000, 105:1067-1075.
47. Rizki G., Arnaboldi L., Gabrielli B., Yan J., Lee G.S., Ng R.K., Turner S.M., Badger T.M., Pitas R.E., Maher J.J. Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. J. Lipid Res. 2006, 47:2280-2290.
48. Cheng Y., Meng Q., Wang C., Li H., Huang Z., Chen S., Xiao F., Guo F. Leucine deprivation decreases fat mass by stimulation of lipolysis in white adipose tissue and upregulation of uncoupling protein 1 (UCP1) in brown adipose tissue. Diabetes 2010, 59:17-25.
49. Dushay J., Chui P.C., Gopalakrishnan G.S., Varela-Rey M., Crawley M., Fisher F.M., Badman M.K., Martinez-Chantar M.L., Maratos-Flier E. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 2010, 139:456-463.
50. Eichmann T.O., Kumari M., Haas J.T., Farese R.V., Zimmermann R., Lass A., Zechner R. Studies on the substrate and stereo/regioselectivity of adipose triglyceride lipase, hormone-sensitive lipase, and diacylglycerol-O-acyltransferases. J. Biol. Chem. 2012, 287:41446-41457.
51. Haemmerle G., Moustafa T., Woelkart G., Buttner S., Schmidt A., van de Weijer T., Hesselink M., Jaeger D., Kienesberger P.C., Zierler K., Schreiber R., Eichmann T., Kolb D., Kotzbeck P., Schweiger M., Kumari M., Eder S., Schoiswohl G., Wongsiriroj N., Pollak N.M., Radner F.P., Preiss-Landl K., Kolbe T., Rulicke T., Pieske B., Trauner M., Lass A., Zimmermann R., Hoefler G., Cinti S., Kershaw E.E., Schrauwen P., Madeo F., Mayer B., Zechner R. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1. Nat. Med. 2011, 17:1076-1085.
52. Ip E., Farrell G.C., Robertson G., Hall P., Kirsch R., Leclercq I. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 2003, 38:123-132.
53. Yilmaz Y., Ones T., Purnak T., Ozguven S., Kurt R., Atug O., Turoglu H.T., Imeryuz N. Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans. Aliment. Pharmacol. Ther. 2011, 34:318-323.
54. Bartelt A., Heeren J. Adipose tissue browning and metabolic health, Nature reviews. Endocrinology 2014, 10:24-36.